Session 3, Presentation 1, IFPMA
3 March 2023
| Standards

Overview
The sixth meeting of the GLG Session 3, International Federation of Pharmaceutical Manufacturers & Associations presentation.
James Andersen, Executive Director, Global Health, IFPMA, gave an overview of private sector engagement in the AMR response, including the 2016 Davos Declaration, work in the life sciences sector, and activities of the AMR Action Fund and the AMR Industry Alliance.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance